Mesoblast Ltd Sponsored ADR is a biotechnology company focused on developing regenerative medicine products and allogeneic, off-the-shelf cellular therapies. The company’s platform is built around mesenchymal lineage cell technology designed for use across severe inflammatory and immune-mediated conditions, as well as selected cardiovascular and spine-related disorders. Its current pipeline includes cell-based medicines intended for hospital and specialist care settings, reflecting a focus on complex diseases with limited treatment options. Mesoblast operates through research, development, and commercialization activities across multiple regions, including Australia, the United States, Singapore, and Switzerland. As an ADR, Mesoblast Ltd Sponsored ADR gives U.S. investors access to the company’s underlying ordinary shares while representing a global healthcare business centered on advanced cell therapy and regenerative medicine.
Website55 Collins Street
Melbourne, VIC, 3000
Australia
Tipranks Press Release.
RYONCIL Market Share Expands; Phase 3 Back Pain Trial Completes Treatment
Investors talking about MESO also mention
What share of all stock conversation is about MESO?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% 0 | 0% 0 | 0% +0 | 0% 0 |
Of the messages about MESO that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | 100% 0 | 100% 0 | 91.27% +0.84 | ||
| Bearish | — | 0% 0 | 0% 0 | 8.73% -0.84 |
Of the messages about MESO that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | — | 100% | 100% | 30.82% | ||
| Controversies | — | 0% | 0% | 2.84% | ||
| Earnings | — | 0% | 0% | 7.34% | ||
| Analysts | — | 0% | 0% | 21.53% | ||
| Macro | — | 0% | 0% | 27.2% | ||
| Technical Analysis | — | 0% | 0% | 10.27% |
Of the messages about MESO, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | — | 11.25% | 11.85% | 48.6% | ||
| Newcomers | — | 88.75% | 88.15% | 51.4% |